CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution
Go back to CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution| Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) | Delayed: 19.75 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.75 | 52 Week High | $24.48 | |||
| Open | $8.75 | 52 Week Low | $10.44 | |||
| Day High | $19.75 | P/E | N/A | |||
| Day Low | $19.75 | EPS | $-100.00 | |||
| Volume | 100 | |||||
| General Electric (NYSE: GE) | Delayed: 327.09 +7.31 (2.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $319.78 | 52 Week High | $33.00 | |||
| Open | $321.90 | 52 Week Low | $27.10 | |||
| Day High | $329.17 | P/E | 222.51 | |||
| Day Low | $319.64 | EPS | $1.47 | |||
| Volume | 4,290,220 | |||||
